Latest Trace Neuroscience News & Updates

See the latest news and media coverage for Trace Neuroscience. We track all announcements, press releases, and industry mentions in real time, all in one place.

Trace Neuroscience

Biotechnology company developing genetic medicines for ALS

traceneuro.com

Headquarters: South San Francisco, United States
Founded year: 2024
Company type: Private company
Number of employees: 20–50
Industry: Pharmaceuticals

Last updated Today

Latest news about Trace Neuroscience

In short: Trace Neuroscience launched with $101 million in funding to develop genomic therapies for amyotrophic lateral sclerosis.

Company announcements

August 7 Trace Neuroscience

Trace Neuroscience executives participate in an ALS charity splash

The company joined patients and advocates in South San Francisco to fund research and increase public awareness.

June 26 Trace Neuroscience

Trace Neuroscience explores ALS therapies at BIO2026

The chief business officer joined a leadership panel on biotech pipeline strategy while networking with industry professionals to advance collaborative therapeutic development.

June 22 Trace Neuroscience

Trace Neuroscience initiates global clinical development for TRCN-1023

The antisense oligonucleotide targets UNC13A protein function to treat ALS across European sites and a Chinese partnership.

June 18 Trace Neuroscience

Trace Neuroscience presents two clinical trial posters at ENCALS2026 in Madrid

The leadership team discusses TRCN-1023 safety profiles and digital health evaluation frameworks for amyotrophic lateral sclerosis therapies.

Media coverage

August 10 BioPharma Dive

How a Biogen drug set the stage for a new biotech targeting ALS | BioPharma Dive

Trace Neuroscience, which launched this week with $101 million, benefited from last year’s approval of Qalsody. Its CEO spoke with BioPharma Dive about how the...

June 22 Nature

Trace Neuroscience

The Nature Index tracks primary research articles from 178 applied, health, natural and social sciences journals, across many different publishers, chosen by an independent group...

March 25 BioSpace

Trace Unites ALS Teams Behind a Target That Could Broaden Treatment Access - BioSpace

Trace Neuroscience, a member of BioSpace’s NextGen Class of 2026, has learned from the success of Biogen’s Qalsody and aims to bring more treatment options...

1 April 2025 Yahoo Finance

Unlearn and Trace Neuroscience Partner to Optimize ALS Clinical Trial

Collaboration will support trial planning for Trace Neuroscience’s upcoming Phase 1/2 clinical trial in ALS SAN FRANCISCO & SOUTH SAN FRANCISCO, Calif., April 01, 2025--(BUSINESS...

Never miss news about Trace Neuroscience

Track Trace Neuroscience and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.

Trace Neuroscience competitors & trending companies

Browse news for competitors to Trace Neuroscience and other trending companies.